Ingevity (NGVT) Change in Accured Expenses (2015 - 2026)

Ingevity (NGVT) has 12 years of Change in Accured Expenses data on file, last reported at $4.4 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $4.4 million, up 175.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.3 million (down 476.67% YoY), and the FY2025 annual result was -$14.1 million, down 1310.0% from the prior year.
• Change in Accured Expenses climbed to $4.4 million in Q1 2026 per NGVT's latest filing, from -$15.1 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $22.6 million in Q3 2022 and troughed at -$20.6 million in Q2 2022.
• A 5-year average of -$1.0 million and a median of $700000.0 in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses jumped 613.64% in 2022, then plunged 1500.0% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at -$4.5 million in 2022, then sank by 271.11% to -$16.7 million in 2023, then jumped by 45.51% to -$9.1 million in 2024, then slumped by 65.93% to -$15.1 million in 2025, then surged by 129.14% to $4.4 million in 2026.
• Business Quant data shows NGVT's Change in Accured Expenses at $4.4 million in Q1 2026, -$15.1 million in Q4 2025, and $9.2 million in Q3 2025.